“…The lack of patient-centered care for lymphedema symptoms has been evidenced by > 40% of breast cancer survivors never receiving information about lymphedema ( Fu et al, 2010a , Ridner et al, 2011a ). In spite of the growing body of evidence linking the experience of lymphedema symptoms to poor QOL which are critical to cancer survivorship ( Fu et al, 2013 , Passik and McDonald, 1998 , Ridner, 2005 , Radina et al, 2015 ), the experience of lymphedema symptoms is often not valued as an essential factor that impact breast cancer survivors' QOL, therefore is not considered essential for patient-centered outcome, assessment or inclusion in clinical research and practice. In addition, oftentimes clinicians' intentions for helping breast cancer survivors are impeded by lack of information about lymphedema symptoms, lack of guidance in how to assess lymphedema symptoms, and lack of standardized and effective interventions for managing lymphedema symptoms ( Fu et al, 2012 , Ryan et al, 2012 ).…”